Wu Xiaoxia, Long Guo, Peng Weiting, Wan Qiquan
Nursing Department, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, People's Republic of China.
Department of Medical Intensive Care Unit, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, People's Republic of China.
Infect Dis Ther. 2022 Aug;11(4):1461-1477. doi: 10.1007/s40121-022-00649-1. Epub 2022 May 13.
Infections caused by Gram-negative bacteria, in particular carbapenem-resistant organisms (CRO), pose a great threat to liver transplant (LT) recipients. Understanding the risk factors for Gram-negative and CRO infections and the drug resistance of corresponding bacteria will help guide the prevention and treatment of these infections.
Data on the composition, distribution and drug resistance of Gram-negative bacteria and CRO among LT recipients were collected. The risk factors for Gram-negative and CRO infections were identified via univariate and multivariate analysis.
A total of 45 episodes of Gram-negative infection, including 20 episodes of CRO infection, occurred in 19.9% (27/136) of LT recipients. Klebsiella pneumoniae was the dominant pathogenic bacteria (14/45; 31.1%). The most common site of infection was the abdominal cavity/bile duct (11/27; 40.7%). Eleven (8.1%) patients died within 2 months after LT, and two deaths were related to Gram-negative infection. Gram-negative bacteria were relatively sensitive to tigecycline and polymyxin B, with resistance of 26.7 and 11.1%, respectively. CRO had lower resistance to ceftazidime/avibactam (45.5%) and polymyxin B (10%). A univariate analysis showed that male sex, infection within 2 months prior to LT, duration of surgery ≥ 400 min, reoperation, indwelling urethral catheter use ≥ 3 days and elevated alanine aminotransferase on day 1 post-LT were associated with Gram-negative infection. Multivariate logistic regression analysis revealed that infection within 2 months prior to LT [odds ratio (OR) = 4.426, 95%CI: 1.634-11.99, P = 0.003], duration of surgery ≥ 400 min [OR = 3.047, 95%CI: 1.194-7.773, P = 0.02] and indwelling urethral catheter use ≥ 3 days [OR = 5.728, 95%CI: 1.226-26.763, P = 0.026] were independent risk factors for Gram-negative infection after LT, and that only carbapenem use ≥ 3 days within 15 days prior to infection [OR = 14, 95%CI: 1.862-105.268, P = 0.01] was related to the occurrence of CRO infections.
The incidence of Gram-negative and CRO infections was high in the early post-LT period. The most common infection site was the abdominal cavity/bile duct, and the dominant pathogen was K. pneumoniae. Patients with infections within 2 months prior to LT, prolonged surgery time or delayed urethral catheter removal were prone to Gram-negative infection. Carbapenem exposure was correlated with CRO infections.
革兰氏阴性菌引起的感染,尤其是耐碳青霉烯类微生物(CRO)感染,对肝移植(LT)受者构成巨大威胁。了解革兰氏阴性菌和CRO感染的危险因素以及相应细菌的耐药性,将有助于指导这些感染的预防和治疗。
收集LT受者中革兰氏阴性菌和CRO的组成、分布及耐药性数据。通过单因素和多因素分析确定革兰氏阴性菌和CRO感染的危险因素。
19.9%(27/136)的LT受者共发生45次革兰氏阴性菌感染,其中包括20次CRO感染。肺炎克雷伯菌是主要病原菌(14/45;31.1%)。最常见的感染部位是腹腔/胆管(11/27;40.7%)。11例(8.1%)患者在LT后2个月内死亡,2例死亡与革兰氏阴性菌感染有关。革兰氏阴性菌对替加环素和多粘菌素B相对敏感,耐药率分别为26.7%和11.1%。CRO对头孢他啶/阿维巴坦(45.5%)和多粘菌素B(10%)的耐药性较低。单因素分析显示,男性、LT前2个月内感染、手术时间≥400分钟、再次手术、留置导尿管使用≥3天以及LT后第1天丙氨酸转氨酶升高与革兰氏阴性菌感染有关。多因素logistic回归分析显示,LT前2个月内感染[比值比(OR)=4.426,95%可信区间:1.634-11.99,P=0.003]、手术时间≥400分钟[OR=3.047,95%可信区间:1.194-7.773,P=0.02]和留置导尿管使用≥3天[OR=5.728,95%可信区间:1.226-26.763,P=0.026]是LT后革兰氏阴性菌感染的独立危险因素,而仅感染前15天内碳青霉烯类药物使用≥3天[OR=14,95%可信区间:1.862-105.268,P=0.01]与CRO感染的发生有关。
LT术后早期革兰氏阴性菌和CRO感染发生率较高。最常见的感染部位是腹腔/胆管,主要病原菌是肺炎克雷伯菌。LT前2个月内感染、手术时间延长或导尿管拔除延迟的患者易发生革兰氏阴性菌感染。碳青霉烯类药物暴露与CRO感染相关。